ArticleOncotarget2017

Alpha-glucosidase inhibitor use is associated with decreased colorectal neoplasia risk in patients with type 2 diabetes mellitus receiving colonoscopy: a retrospective study.

Yohei Horibe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.